Advertisement.
Advertisement.
Advertisement.
Market Cap | 7.22B |
Volume | 2.22M |
52-Wk High | 45.70 |
52-Wk Low | 21.50 |
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Nectar Lifesciences Ltd. market cap is 7.22B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Nectar Lifesciences Ltd. 52 week high is 45.70 as of July 27, 2024.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Nectar Lifesciences Ltd. 52 week low is 21.50 as of July 27, 2024.
Nectar Lifesciences Ltd. stock price today is 32.28.
Nectar Lifesciences Ltd. stock price yesterday was 30.38.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Nectar Lifesciences Ltd.’s P/E ratio is 142.24.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Nectar Lifesciences Ltd. P/B ratio is 0.6763.
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Nectar Lifesciences Ltd.'s EBITDA is 7.90.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Nectar Lifesciences Ltd. 50-day moving average is 31.62.